Overview
Satoru Kitazono practices practicing medicine in Tokyo, Japan.
Mr. Kitazono is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 72 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Satoru Kitazono
Is Satoru Kitazono a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Satoru Kitazono is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Satoru Kitazono participate in research or clinical trials?
Yes. Satoru Kitazono has published 72 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Satoru Kitazono's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Kitazono isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Kitazono isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerMr. Kitazono isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- HypertensionMr. Kitazono isExperienced. Learn about Hypertension.
- Inflammatory Myofibroblastic TumorMr. Kitazono isExperienced. Learn about Inflammatory Myofibroblastic Tumor.
- Lung AdenocarcinomaMr. Kitazono isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesMr. Kitazono isExperienced. Learn about Lung Metastases.
- Lynch SyndromeMr. Kitazono isExperienced. Learn about Lynch Syndrome.
- Metastatic Pleural TumorMr. Kitazono isExperienced. Learn about Metastatic Pleural Tumor.
- Minimal Change DiseaseMr. Kitazono isExperienced. Learn about Minimal Change Disease.
- PIK3CA-Related Overgrowth SpectrumMr. Kitazono isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- PneumoniaMr. Kitazono isExperienced. Learn about Pneumonia.
- Pulmonary HypertensionMr. Kitazono isExperienced. Learn about Pulmonary Hypertension.
- Small Cell Lung Cancer (SCLC)Mr. Kitazono isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Thymic Epithelial TumorMr. Kitazono isExperienced. Learn about Thymic Epithelial Tumor.
- Trophoblastic Tumor Placental SiteMr. Kitazono isExperienced. Learn about Trophoblastic Tumor Placental Site.